VIVUS Appoints Changjin (CJ) Wang, Ph.D. as Vice President of Business Development (FinanzNachrichten)
MOUNTAIN VIEW, Calif., Nov. 1 /PRNewswire-FirstCall/ -- VIVUS, ( Nachrichten ) Inc. , a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products addressing obesity and sexual health, today announced the appointment of CJ Wang, Ph.D., as Vice President of Business Development.

Bradley Pharmaceuticals Announces Polyphenon E(R) Ointment, 15% Approved by FDA (PR Newswire via Yahoo! Finance)
Bradley Pharmaceuticals, Inc. announced today that the Company has been notified by MediGene AG that MediGene received FDA approval from the U.S. Food and Drug Administration to market Polyphenon E Ointment, 15%, a new drug indicated for the treatment of external genital and perianal warts and patented through 2017.